Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
Aster has appointed Ernst & Young LLP (EY) to assess the applications, overseeing shortlisting with an independent panel, and presenting finalists to the Grand Jury.
Reflecting on the entries this year, Dr Azad Moopen, Founder Chairman of Aster DM Healthcare, said ' It has been inspiring to observe the evolution of the platform, and its impact on the global nursing community. The remarkable response to the 4th edition, with over 100,000 registrations from 199 countries, underscores the global significance of this initiative. We eagerly anticipate meeting the top 10 finalists, distinguished nurses from around the world, as they compete for the esteemed award and a $250,000 prize."
In the previous edition, Philippine-based Nurse Maria Victoria Juan emerged as the winner for her exceptional contributions in leadership, nursing education and community service.
About Aster DM Healthcare
Founded in 1987 by Dr. Azad Moopen, Aster DM Healthcare is a leading integrated healthcare provider, with a strong presence across seven countries. Aster is committed to the vision of providing accessible and high-quality healthcare, from primary to quaternary services, with its promise of 'We will treat you well'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Small Medical Practices Are Sitting Ducks for Healthcare Cybercrime
SAN FRANCISCO--(BUSINESS WIRE)--Over 90% of U.S. healthcare providers operate as small organizations, yet a new Paubox report titled "What small healthcare practices get wrong about HIPAA and email security" reveals these practices are unknowingly exposing themselves to cyber attacks and federal compliance violations. 98% of small healthcare organizations falsely believe they're HIPAA compliant Share The study of 214 healthcare IT leaders and practice managers at organizations with fewer than 250 employees found that nearly all small practices (98%) claim their platforms "encrypt emails by default"—but most are using common tools like Microsoft 365 or Google Workspace that often fail to provide actual protection. "Nearly half of healthcare email breaches stem from Microsoft 365 alone," the survey found. The problem is that encryption may drop if a recipient's server doesn't support modern protocols, often without any alert to the sender—leaving protected health information completely exposed. The confidence crisis More than 80% of small practices expressed confidence in their current HIPAA compliance posture, but the reality is far different. The survey found widespread misconceptions that are creating massive compliance gaps: 83% believe patient consent removes the need for encryption—a costly misunderstanding. Federal regulations still require "appropriate safeguards" under the HIPAA Security Rule, even when patients agree to electronic communication. Getting a patient's okay to email doesn't eliminate the legal requirement for encryption and other protective measures. 64% believe patient portals are required for HIPAA compliance—yet the regulations say the opposite. HIPAA explicitly gives patients the right to request communication "by alternative means or at alternative locations, if reasonable." Portals are just one option among many, including secure direct email when proper safeguards are in place. 20% don't utilize any form of email archiving or audit trail—leaving one in five practices unable to investigate incidents after they happen or prove compliance during federal audits. These misconceptions create compliance violations that practices don't even realize exist, with healthcare providers unknowingly breaking federal law while genuinely believing they're following the rules. Cybercriminals target the vulnerable Phishing attacks—the leading cause of healthcare breaches—now account for over 70% of healthcare data breaches as of 2024. Small practices are prime targets because they typically lack dedicated security staff, formal training programs, or technical defenses. The survey found that 43% of small healthcare organizations reported experiencing a phishing or spoofing incident in the past year. Meanwhile, about 50% of these organizations lack anti-phishing controls beyond default spam filters, and nearly 99% have not implemented secure email transfer protocols. "Phishing attacks have evolved—they're faster, smarter, and relentless," noted Paubox CEO, Hoala Greevy. "It's not about one-off scams anymore; it's deception at scale." Beyond the breach When breaches occur, small practices face the same serious consequences as large health systems. Recent examples from the past year include: Solara Medical : $9.76 million class-action settlement following a phishing attack : $9.76 million class-action settlement following a phishing attack Sunrise Community Health : Email compromise affecting 54,000+ patients : Email compromise affecting 54,000+ patients Salud Family Health: Phishing attack exposing 80,000+ records Even smaller penalties come with major operational costs. Agape Health, a North Carolina clinic, paid $25,000 for emailing protected health information unencrypted to the wrong recipient, while Vision Upright MRI faced a $5,000 fine plus two years of federal monitoring after a server breach exposed over 21,000 individuals' medical imaging records. In 2025, healthcare breaches took an average of 224 days to detect and another 84 days to contain—over 10 months total. Without proper audit trails, many small organizations lack the systems to spot breaches until it's too late. Stretched thin and vulnerable The survey found that small healthcare practices are operating under dangerous constraints that create the perfect storm for security failures: One-third report not having enough time for compliance tasks—meaning critical security measures get pushed aside during busy patient care schedules. The same number have no clear policies or procedures in place, leaving staff to make up security protocols on the fly. Only half have phishing or spoofing protection enabled, despite facing the same sophisticated attacks that target major health systems. Meanwhile, the average small healthcare employee has access to more than 5,500 sensitive files—creating massive exposure when those unprotected phishing emails inevitably get through. This combination of time pressure, unclear guidance, and broad data access means a single clicked link can expose thousands of patient records. It's a vulnerability that cybercriminals are increasingly exploiting. What HIPAA investigators look for When HHS investigators arrive after a breach, they look for specific documentation that most small practices can't provide: Proof that protected health information was encrypted in transit—not just that platforms "support" encryption Audit logs showing who sent what to whom and whether it was properly protected Evidence of risk assessments documenting understood vulnerabilities Incident response procedures for when things go wrong "Every organization, no matter the size, is required to comply with the HIPAA Security Rule," emphasized Melanie Fontes Rainer, Director of the HHS Office for Civil Rights. "Risk assessments are not optional—they're foundational." The path forward With federal enforcement ramping up and cybercriminals increasingly targeting small practices, the window for voluntary compliance is closing fast. The practices that are getting ahead of this crisis share a common strategy: they've stopped relying on overworked staff to make perfect security decisions every time. Instead, they're implementing systems that encrypt every message automatically, maintain detailed audit trails without extra effort, and block phishing attacks before employees ever see them. "The cost of compliance is far less than the cost of a breach," the survey noted—and recent settlements prove it. At $25,000 to $9.76 million per incident, even "small" violations can devastate a practice's finances and reputation. For the 90% of healthcare providers operating as small organizations, the math is simple: invest in automated protection now, or face the much higher costs of breach response, federal penalties, and lost patient trust later. The choice is becoming less optional every day. The complete report, "What small healthcare practices get wrong about HIPAA and email security," is available for download at About Paubox Paubox is a leader in HIPAA compliant communication and marketing solutions for healthcare organizations. According to G2 rankings, Paubox leads the industry for Best Secure Email Gateway, Email Security, HIPAA Compliant Messaging Software, and Email Encryption solution, and is the only HIPAA compliant email company listed on G2's 2025 Best Healthcare Software Products. Paubox solutions include Paubox Email Suite, Paubox Marketing, Paubox Email API, Paubox Forms, and Paubox Texting. Launched in 2015, Paubox is trusted by over 7,000 healthcare organizations, including Cost Plus Drugs, Covenant Health, Devry University, and SimonMed Imaging.
Yahoo
2 hours ago
- Yahoo
Do Wall Street Analysts Like Solventum Stock?
With a market cap of $12.4 billion, Solventum Corporation (SOLV) is an independent healthcare company that develops, manufactures, and markets innovative solutions to meet critical patient and customer needs worldwide. Its business spans four segments: Medsurg; Dental Solutions; Health Information Systems; and Purification and Filtration, serving healthcare providers through direct sales, distribution, and digital platforms. Shares of the Maplewood, Minnesota-based company have outperformed the broader market over the past 52 weeks. SOLV stock has increased 21.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.4%. However, shares of the company have risen 8.1% on a YTD basis, lagging behind SPX's 9.7% return. More News from Barchart Lyft Generates Huge FCF Margins - LYFT Stock Is Too Cheap Trade the Warren Buffett Rally in UnitedHealth Stock With This High-Reward, Low-Risk Options Strategy Powell, Trump Talks and Other Can't Miss Items this Week Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. Looking closer, Solventum stock has also outpaced the Health Care Select Sector SPDR Fund's (XLV) 10.8% decrease over the past 52 weeks. Shares of Solventum rose 2% on Aug. 7 after the company reported Q2 2025 adjusted EPS of $1.69 and revenue of $2.2 billion, above Wall Street forecasts. Growth was driven largely by its MedSurg segment, where sales rose 4.8% to $1.2 billion, reflecting robust demand for wound care and surgical sterilization products, alongside lower expenses. Additionally, management raised its full-year adjusted EPS guidance to $5.80 - $5.95, as easing U.S.-China tariff risks reduced expected headwinds. For the fiscal year ending in December 2025, analysts expect SOLV's adjusted EPS to decline 11.9% year-over-year to $5.90. The company's earnings surprise history is mixed. It topped the consensus estimates in three of the last four quarters while missing on another occasion. Among the 13 analysts covering the stock, the consensus rating is a 'Moderate Buy.' That's based on four 'Strong Buy' ratings, eight 'Holds,' and one 'Strong Sell.' This configuration is more bullish than three months ago, with one 'Strong Buy' rating on the stock. On Aug. 8, Piper Sandler increased its price target on Solventum to $94 while maintaining an 'Overweight' rating. As of writing, the stock is trading below the mean price target of $87.12. The Street-high price target of $103 implies a modest potential upside of 44.2% from the current price levels. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Los Angeles Times
2 hours ago
- Los Angeles Times
U.S. pediatricians' new COVID-19 vaccine recommendations differ from CDC advice
NEW YORK — For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group's new COVID-19 recommendations — released Tuesday — come amid a tumultuous year for public health, as vaccine skeptics have come into power in the new Trump administration and government guidance has become increasingly confusing. This isn't going to help, acknowledged Dr. James Campbell, vice chair of the AAP infectious diseases committee. 'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. That differs from guidance established under U.S. Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. In a statement, Department of Health and Human Services spokesperson Andrew Nixon said 'the AAP is undermining national immunization policymaking with baseless political attacks.' He accused the group of putting commercial interests ahead of public health, noting that vaccine manufacturers have been donors to the AAP's Friends of Children Fund. The fund is currently paying for projects on a range of topics, including health equity and prevention of injuries and deaths from firearms. The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient. Stobbe writes for the Associated Press. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
